IperionX prices $50M public offering led by US institutions
IperionX Limited priced a public offering of 2,275,000 ADSs at $21.98 per share, targeting $50 million in gross proceeds to fund titanium production expansion and corporate purposes. The offering, led by Cantor with Roth Capital Partners and B. Riley Securities as co-managers, is expected to close on July 9, 2026. Proceeds will support the Titanium Manufacturing Campus in Virginia and the Camden-Titan Project in Tennessee.

*this image is generated using AI for illustrative purposes only.
IperionX Limited has priced an underwritten public offering of 2,275,000 American Depositary Shares (ADSs) at $21.98 per ADS, aiming to raise aggregate gross proceeds of approximately $50 million. The offering, led by U.S. institutional investors, is expected to close on July 9, 2026, subject to customary closing conditions. Each ADS represents 10 of the company's ordinary shares, with the issuance utilizing the company's placement capacity under Listing Rule 7.1.
Proceeds from the offering will be allocated to continue the commercialization and scale-up of titanium and metal alloy production technologies. Key areas of investment include the expansion of the company’s Titanium Manufacturing Campus in Virginia, associated titanium metal research and development activities, and the continued development of the Camden-Titan Project in Tennessee. Funds will also support general corporate purposes.
Cantor is acting as the sole book-running manager for the offering, while Roth Capital Partners and B. Riley Securities are serving as co-managers. The offering is being conducted under a shelf registration statement on Form F-3 (File No. 333-273519), which was filed with the U.S. Securities and Exchange Commission (SEC) on July 28, 2023, and declared effective on August 9, 2023.
The offering is made available only through a prospectus supplement and accompanying prospectus, which are part of the registration statement. A preliminary prospectus supplement has been filed with the SEC and is available on the SEC’s website and the ASX’s website. A final prospectus supplement will be filed and made available upon completion of the offering.
Offering Details
| Detail | Description |
|---|---|
| Total ADSs Offered | 2,275,000 |
| Price per ADS | $21.98 |
| Gross Proceeds | Approximately $50 million |
| Ordinary Shares per ADS | 10 |
| Expected Closing Date | July 9, 2026 |
| Lead Manager | Cantor |
| Co-Managers | Roth Capital Partners, B. Riley Securities |
IperionX focuses on producing high-performance titanium alloys using patented technologies aimed at lowering energy consumption, costs, and carbon emissions. The company has transitioned to a commercial producer of titanium metal products in the United States, leveraging its portfolio of technologies to create sustainable competitive advantages.
How will the $50 million raised impact IperionX's production capacity at the Titanium Manufacturing Campus in Virginia?
What are the expected timelines for the commercialization of the Camden-Titan Project in Tennessee?
How will the influx of capital influence IperionX's competitive position in the titanium and metal alloy markets?

























